equitybuy

LFMDP

Trust-weighted public proof page for LFMDP. See which authors support it, which ticker theses it belongs to, and how thesis calls have performed.

Opportunity

22 / 100

Current score

0.36

Thesis calls

Active decisions

Recent proof-backed thesis calls

Public preview of asset-level thesis calls linked to source content, observed prices, and outcomes.

LifeMD, Inc.sec_filingsopen

Cover page of LifeMD, Inc. (LFMD) FY2025 10-K (period ended 2025-12-31). No financial statements, guidance, risk-factor changes, or MD&A details provided in the excerpt, so actionable trading signals are limited. Identified listed securities: LFMD common and LFMDP preferred on Nasdaq Global Market.

Mentioned: Mar 10, 2026, 4:56 PM EDTConviction: 36 / 100

View source

Source: LFMD 10-K report for 2025-12-31

LifeMD, Inc.sec_filingsopen

Excerpt is only the cover/header of LifeMD, Inc. (LFMD) Form 10-Q for quarter ended 2025-06-30. It confirms ticker/listings (LFMD common; LFMDP 8.875% Series A cumulative perpetual preferred) and that the company is current on SEC filing requirements. No financial statements, KPIs, guidance, risk-factor updates, or MD&A content provided, so investable conclusions are limited.

Mentioned: Aug 5, 2025, 4:46 PM EDTConviction: 25 / 100

View source

Source: LFMD 10-Q report for 2025-06-30